EUDA Health Holdings EBIT Margin 2022-2024 | EUDA
Current and historical EBIT (Earnings Before Interest & Taxes) margin for EUDA Health Holdings (EUDA) over the last 10 years. The current EBIT profit margin for EUDA Health Holdings as of June 30, 2024 is .
| EUDA Health Holdings EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.092B | $0.004B |
| EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.020B | 52.51 |
| Tempus AI (TEM) | United States | $8.898B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.354B | 118.21 |
| Inspire Medical Systems (INSP) | United States | $4.713B | 91.55 |
| IRhythm Technologies (IRTC) | United States | $3.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.848B | 213.46 |
| Enovis (ENOV) | United States | $1.975B | 12.22 |
| Schrodinger (SDGR) | United States | $1.872B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Phreesia (PHR) | United States | $1.467B | 0.00 |
| Omnicell (OMCL) | United States | $1.464B | 31.58 |
| Azenta (AZTA) | United States | $1.204B | 56.04 |
| 10x Genomics (TXG) | United States | $1.011B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.536B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 307.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Standard BioTools (LAB) | United States | $0.421B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.363B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.209B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| Pulmonx (LUNG) | United States | $0.194B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.33 |
| 111 (YI) | China | $0.071B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Outset Medical (OM) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |